These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32432400)

  • 1. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
    Shih AW; Yan MTS; Elahie AL; Barty RL; Liu Y; Berardi P; Azzam M; Siddiqui R; Parvizian MK; Mcdougall T; Heddle NM; Al-Habsi KS; Goldman M; Cote J; Athale U; Verhovsek MM
    Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant RH alleles and Rh immunisation in patients with sickle cell disease.
    Sippert E; Fujita CR; Machado D; Guelsin G; Gaspardi AC; Pellegrino J; Gilli S; Saad SS; Castilho L
    Blood Transfus; 2015 Jan; 13(1):72-7. PubMed ID: 24960646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
    Rodrigues C; Sell AM; Guelsin GAS; Higa TT; Pagliarini E Silva S; Macedo LC; Sippert EÂ; de Alencar JB; Zanette Â; Acorsi CRL; Castilho L; Visentainer JEL
    Transfus Med; 2017 Dec; 27(6):437-443. PubMed ID: 28881103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease patients in two London trusts: Genotyping including RH variants.
    Hui YMT; Gurung K; Layton DM; Ibidapo M; Grimsley S; Regan F
    Transfus Med; 2022 Jun; 32(3):210-220. PubMed ID: 34850464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
    Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do I incorporate red cell genotyping to improve chronic transfusion therapy?
    Van Buren NL; Gorlin JB; Corby SM; Cassidy S; FritchLilla S; Nelson SC; Westhoff CM
    Transfusion; 2020 Jan; 60(1):16-25. PubMed ID: 31758587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Dinardo CL; Oliveira TGM; Kelly S; Ashley-Koch A; Telen M; Schmidt LC; Castilho S; Melo K; Dezan MR; Wheeler MM; Johnsen JM; Nickerson DA; Jain D; Custer B; Pereira AC; Sabino EC;
    Transfusion; 2021 Feb; 61(2):603-616. PubMed ID: 33231305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD).
    Leal I; Dos Santos TD; Gilli S; Castilho L
    Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
    Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
    Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group genotyping in alloimmunized multi-transfused thalassemia patients from Iran.
    Sarihi R; Oodi A; Dadkhah Tehrani R; Jalali SF; Mardani F; Azarkeivan A; Gudarzi S; Amirizadeh N
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1701. PubMed ID: 33963817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
    Regalado-Artamendi I; Pérez-Corral AM; García-Morín M; Cela E; Beléndez C; Bardón-Cancho EJ; Pérez-Rus G; Pérez-Sánchez I; Pascual C; Monsalvo S; Falero C; Díez-Martín JL; Anguita J
    Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duffy blood group phenotype-genotype correlations using high-resolution melting analysis PCR and microarray reveal complex cases including a new null FY*A allele: the role for sequencing in genotyping algorithms.
    Lopez GH; Morrison J; Condon JA; Wilson B; Martin JR; Liew YW; Flower RL; Hyland CA
    Vox Sang; 2015 Oct; 109(3):296-303. PubMed ID: 25900316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.
    Guelsin GA; Rodrigues C; Visentainer JE; De Melo Campos P; Traina F; Gilli SC; Saad ST; Castilho L
    Blood Transfus; 2015 Jan; 13(1):53-8. PubMed ID: 24960644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.
    Pirenne F; Floch A; Habibi A
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):689-695. PubMed ID: 34889373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in providing compatible blood with Rh genotype-matching in Brazilian patients with sickle cell disease.
    Santos TD; Macedo MD; Menegati SFP; Gilli S; Castilho L
    Transfus Med; 2019 Dec; 29(6):423-429. PubMed ID: 31631427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.
    Wilkinson K; Harris S; Gaur P; Haile A; Armour R; Teramura G; Delaney M
    Transfusion; 2012 Feb; 52(2):381-8. PubMed ID: 21827505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
    Yee MEM; Josephson CD; Winkler AM; Webb J; Luban NLC; Leong T; Stowell SR; Fasano RM
    Transfusion; 2017 Nov; 57(11):2738-2746. PubMed ID: 28840600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.